Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Senti Biosciences (SNTI) Leases (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Leases data on record, last reported at $12.3 million in Q3 2025.

  • For Q3 2025, Leases fell 15.26% year-over-year to $12.3 million; the TTM value through Sep 2025 reached $12.3 million, down 15.26%, while the annual FY2024 figure was $13.9 million, 14.29% down from the prior year.
  • Leases reached $12.3 million in Q3 2025 per SNTI's latest filing, down from $12.8 million in the prior quarter.
  • Across five years, Leases topped out at $20.7 million in Q4 2021 and bottomed at $12.3 million in Q3 2025.
  • Average Leases over 5 years is $16.3 million, with a median of $16.3 million recorded in 2023.
  • Peak YoY movement for Leases: dropped 9.88% in 2023, then fell 16.05% in 2025.
  • A 5-year view of Leases shows it stood at $20.7 million in 2021, then fell by 11.06% to $18.4 million in 2022, then fell by 11.64% to $16.3 million in 2023, then decreased by 14.29% to $13.9 million in 2024, then dropped by 12.09% to $12.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $12.3 million in Q3 2025, $12.8 million in Q2 2025, and $13.4 million in Q1 2025.